Sheffield Medical Technologies Inc. regulatory update

SHM's Ion Pharmaceuticals Inc. subsidiary received U.S. Patent No. 5,512,591 covering the use of its anti-proliferative technology to treat non-prostate, non-hormone-dependent solid tumors. Ion's anti-proliferatives inhibit the transport of ions and fluids that are essential for cell division, in addition to inhibiting abnormal cell proliferation. ...